Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Market Cap: S$51.72 Mil (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Singapore Institute Of Advanced Medicine Holdings Market Cap?

Singapore Institute Of Advanced Medicine Holdings SGX:9G2 +3.45% Market Cap is S$51.72 Mil as of Aug. 19, 2026. The stock has 2 warning signs investors should review. Among 690 Healthcare Providers & Services companies, Singapore Institute Of Advanced Medicine Holdings ranks worse than 67.1% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Singapore Institute Of Advanced Medicine Holdings's share price for the quarter that ended in Mar. 2026 was S$0.038364. Singapore Institute Of Advanced Medicine Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 1,316.10 Mil. Therefore, Singapore Institute Of Advanced Medicine Holdings's market cap for the quarter that ended in Mar. 2026 was S$50.49 Mil.

Singapore Institute Of Advanced Medicine Holdings's quarterly market cap increased from Jun. 2025 (S$30.80 Mil) to Dec. 2025 (S$84.97 Mil) but then declined from Dec. 2025 (S$84.97 Mil) to Mar. 2026 (S$50.49 Mil).

Singapore Institute Of Advanced Medicine Holdings's annual market cap increased from Jun. 2023 (S$0.00 Mil) to Jun. 2024 (S$105.86 Mil) but then declined from Jun. 2024 (S$105.86 Mil) to Jun. 2025 (S$30.80 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Singapore Institute Of Advanced Medicine Holdings's Enterprise Value for Today is S$107.86 Mil.


Singapore Institute Of Advanced Medicine Holdings  (SGX:9G2) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Singapore Institute Of Advanced Medicine Holdings Market Cap Related Terms


Singapore Institute Of Advanced Medicine Holdings Market Cap Historical Data

* Premium members only.

The historical data trend for Singapore Institute Of Advanced Medicine Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singapore Institute Of Advanced Medicine Holdings Market Cap Chart

Singapore Institute Of Advanced Medicine Holdings Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Market Cap
0.00 0.00 0.00 105.86 30.80

Singapore Institute Of Advanced Medicine Holdings Quarterly Data
Jun21 Jun22 Jun23 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only 57.65 47.79 30.80 84.97 50.49

SGX:9G2 vs HCA, THC, DVA: Market Cap Comparison

For the Medical Care Facilities subindustry, Singapore Institute Of Advanced Medicine Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Singapore Institute Of Advanced Medicine Holdings Market Cap vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singapore Institute Of Advanced Medicine Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Singapore Institute Of Advanced Medicine Holdings's Market Cap falls into.



Singapore Institute Of Advanced Medicine Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Singapore Institute Of Advanced Medicine Holdings's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as

Market Cap (A: Jun. 2025 )=Share Price (A: Jun. 2025 )*Shares Outstanding (EOP) (A: Jun. 2025 )
=S$0.027135*1134.984
=S$30.80

Singapore Institute Of Advanced Medicine Holdings's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=S$0.038364*1316.101
=S$50.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of S$51.72 Mil mean?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a Market Cap of S$51.72 Mil as of Aug. 19, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. According to the industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #463 out of 690 companies in the Healthcare Providers & Services industry, placing it in the top 67.1%.
Is Singapore Institute Of Advanced Medicine Holdings' Market Cap too high?
Singapore Institute Of Advanced Medicine Holdings' current Market Cap is S$51.72 Mil. Based on the distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #463 out of 690 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Singapore Institute Of Advanced Medicine Holdings' Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #463 out of 690 companies for Market Cap. This places Singapore Institute Of Advanced Medicine Holdings in the lower half of its industry. The industry median Market Cap is 107.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 107.27, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 107.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singapore Institute Of Advanced Medicine Holdings's current Market Cap is S$51.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Institute Of Advanced Medicine Holdings stock overvalued right now?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a current Market Cap of S$51.72 Mil. The current Market Cap is S$51.72 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Singapore Institute Of Advanced Medicine Holdings (SGX:9G2), the current Market Cap is S$51.72 Mil as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Singapore Institute Of Advanced Medicine Holdings Business Description

Address 1 Biopolis Drive, No. 02-01 Amnios, Singapore, SGP, 138622
Singapore Institute of Advanced Medicine Holdings Ltd is a Singapore-based healthcare service provider comprising a medical center, diagnostic imaging facility, nuclear medicine clinic, and radiation oncology service providing proton and X-ray radiotherapy. Its operating segments are: Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services, and Investment Holding. Medical Diagnostics and Treatments include: cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services. Radiation Therapy encompasses proton beam therapy, photon radiation therapy, and Medical oncology. The majority of the company's revenue comes from the Medical Diagnostics and Treatments segment.